v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (unaudited) - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Total DXC Equity
Non- Controlling Interest
Beginning balance (in shares) at Mar. 31, 2021   257,053            
Beginning balance at Mar. 31, 2021 $ 5,308 $ 3 $ 10,761 $ (5,331) $ (302) $ (158) $ 4,973 $ 335
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 197     188     188 9
Other comprehensive income (loss) (72)       (83)   (83) 11
Share-based compensation expense 63   63       63  
Acquisition of treasury stock (13)         (13) (13)  
Share repurchase program (in shares)   (10,618)            
Share repurchase program (363)   (449) 86     (363)  
Stock option exercises and other common stock transactions (in shares)   1,921            
Stock option exercises and other common stock transactions 11   11       11  
Non-controlling interest distributions and other (44)   (3) (1)     (4) (40)
Ending balance (in shares) at Dec. 31, 2021   248,356            
Ending balance at Dec. 31, 2021 5,087 $ 3 10,383 (5,058) (385) (171) 4,772 315
Beginning balance (in shares) at Sep. 30, 2021   255,003            
Beginning balance at Sep. 30, 2021 5,083 $ 3 10,646 (5,225) (482) (170) 4,772 311
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 102     98     98 4
Other comprehensive income (loss) 98       97   97 1
Share-based compensation expense 23   23       23  
Acquisition of treasury stock (1)         (1) (1)  
Share repurchase program (in shares)   (6,756)            
Share repurchase program (213)   (286) 73     (213)  
Stock option exercises and other common stock transactions (in shares)   109            
Non-controlling interest distributions and other (5)     (4)     (4) (1)
Ending balance (in shares) at Dec. 31, 2021   248,356            
Ending balance at Dec. 31, 2021 5,087 $ 3 10,383 (5,058) (385) (171) 4,772 315
Beginning balance (in shares) at Mar. 31, 2022   240,508            
Beginning balance at Mar. 31, 2022 5,375 $ 3 10,057 (4,450) (385) (173) [1] 5,052 323
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 192     188     188 4
Other comprehensive income (loss) (353)       (351)   (351) (2)
Share-based compensation expense 73   73       73  
Acquisition of treasury stock (13)         (13) [1] (13)  
Share repurchase program (in shares)   (10,915)            
Share repurchase program (323) $ (1) (461) 139     (323)  
Stock option exercises and other common stock transactions (in shares)   1,758            
Stock option exercises and other common stock transactions 1   1       1  
Ending balance (in shares) at Dec. 31, 2022   231,351            
Ending balance at Dec. 31, 2022 4,952 $ 2 9,670 (4,123) (736) (186) [1] 4,627 325
Beginning balance (in shares) at Sep. 30, 2022   233,278            
Beginning balance at Sep. 30, 2022 4,936 $ 2 9,733 (4,211) (724) (185) [1] 4,615 321
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 61     59     59 2
Other comprehensive income (loss) (10)       (12)   (12) 2
Share-based compensation expense 24   24       24  
Acquisition of treasury stock (1)         (1) [1] (1)  
Share repurchase program (in shares)   (2,064)            
Share repurchase program (57)   (87) 30     (57)  
Stock option exercises and other common stock transactions (in shares)   137            
Non-controlling interest distributions and other (1)     (1)     (1)  
Ending balance (in shares) at Dec. 31, 2022   231,351            
Ending balance at Dec. 31, 2022 $ 4,952 $ 2 $ 9,670 $ (4,123) $ (736) $ (186) [1] $ 4,627 $ 325
[1] 3,278,690 treasury shares as of December 31, 2022.